A detailed history of Morgan Stanley transactions in Fonar Corp stock. As of the latest transaction made, Morgan Stanley holds 2,106 shares of FONR stock, worth $37,423. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,106
Previous 5,713 63.14%
Holding current value
$37,423
Previous $122,000 72.95%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$14.39 - $20.42 $51,904 - $73,654
-3,607 Reduced 63.14%
2,106 $33,000
Q1 2024

Aug 16, 2024

BUY
$18.84 - $23.24 $67,955 - $83,826
3,607 Added 171.27%
5,713 $122,000
Q1 2024

May 15, 2024

BUY
$18.84 - $23.24 $67,955 - $83,826
3,607 Added 171.27%
5,713 $122,000
Q4 2023

Feb 13, 2024

SELL
$12.52 - $20.5 $1,126 - $1,845
-90 Reduced 4.1%
2,106 $41,000
Q3 2023

Nov 15, 2023

BUY
$15.4 - $17.47 $1,386 - $1,572
90 Added 4.27%
2,196 $33,000
Q1 2023

May 15, 2023

SELL
$15.4 - $18.75 $3,526 - $4,293
-229 Reduced 9.81%
2,106 $34,000
Q4 2022

Feb 14, 2023

SELL
$14.95 - $18.82 $13,544 - $17,050
-906 Reduced 27.95%
2,335 $39,000
Q3 2022

Nov 14, 2022

SELL
$13.31 - $15.36 $26,273 - $30,320
-1,974 Reduced 37.85%
3,241 $45,000
Q2 2022

Oct 27, 2022

SELL
$15.19 - $19.05 $9,964 - $12,496
-656 Reduced 11.17%
5,215 $79,000
Q2 2022

Aug 15, 2022

SELL
$15.19 - $19.05 $9,964 - $12,496
-656 Reduced 11.17%
5,215 $79,000
Q1 2022

Oct 27, 2022

BUY
$14.53 - $19.1 $9,531 - $12,529
656 Added 12.58%
5,871 $109,000
Q1 2022

May 13, 2022

SELL
$14.53 - $19.1 $22,812 - $29,987
-1,570 Reduced 21.1%
5,871 $109,000
Q4 2021

Feb 14, 2022

BUY
$14.55 - $18.6 $2,924 - $3,738
201 Added 2.78%
7,441 $111,000
Q3 2021

Nov 15, 2021

BUY
$15.44 - $17.77 $111,785 - $128,654
7,240 New
7,240 $111,000

Others Institutions Holding FONR

About FONAR CORP


  • Ticker FONR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 6,554,210
  • Market Cap $116M
  • Description
  • FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic servi...
More about FONR
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.